Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trends in Biologics Manufacturing from Drug Substance to Fill/Finish | Contract Pharma

What are you searching for?

Sign in
Ebook

Trends in Biologics Manufacturing from Drug Substance to Fill/Finish

As the biologics market grows, the demand increases for development and manufacturing capabilities.

Released By Catalent

Biopharmaceutical companies and contract manufacturing organizations are investing to increase biomanufacturing and drug product fill-finish capacity in order to keep up with the pace. Fast track approvals, increased focus on orphan diseases and the emergence of personalized medicine are influencing how the industry makes its investment decisions. This ebook examines current and future trends in biologics development and manufacturing and the steps companies are taking to address this changing landscape.

Biopharma Manufacturing Markets
Biomanufacturing contract services and supplies markets continue to expand.
Read More >>

CEO Spotlight — Catalent
A conversation with John Chiminski, CEO of Catalent Pharma Solutions.
Read More >>

Biopharmaceutical Contract Manufacturing Trends
Examining the importance of fill-and-finish operations in today’s biopharma manufacturing market.
Read More >>

Next-Gen Biologics Packaging & Delivery
As the frontier of drug innovation evolves, so must the design of packaging and delivery systems. Read More >>
Read More >>


Request more information from Catalent

Request more information from Catalent

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters